About
Profile
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
BMRN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.02, revenue of $581.3M misses by $26.46M
- BioMarin appoints Alexander Hardy as president and chief executive officer
- BioMarin Pharmaceutical Q3 2023 Earnings Preview
- Bernstein upgrades BioMarin to market perform, citing valuation
- FDA approves use of BioMarin drug Voxzogo in children under 5
- BioMarin a market perform at Raymond James due to growth concerns
- BioMarin Pharmaceutical Non-GAAP EPS of $0.54 beats by $0.07, revenue of $595.3M in-line
- BioMarin Pharmaceutical Q2 2023 Earnings Preview
- BioMarin upgraded at BMO after FDA nod for hemophilia A therapy
- BioMarin granted FDA nod for hemophilia A gene therapy
- Eli Lilly, Humana among best health care names in defensive environment - BofA
- BioMarin Pharmaceutical Non-GAAP EPS of $0.60 beats by $0.20, revenue of $596.4M beats by $26.01M
- BioMarin Pharmaceutical Q1 2023 Earnings Preview
- What is behind biotech M&A resurgence?
- FDA to back accelerated approval pathway for gene therapies
- BioMarin seeks FDA nod to expand use of its Voxzogo treatment in children under five
- BioMarin's Roctavian gets FDA action date extended to end of June
- BridgeBio soars 55% after Phase 2 data for achondroplasia candidate
- BioMarin Pharmaceutical GAAP EPS of $0.00 beats by $0.07, revenue of $537.5M misses by $0.74M
- BioMarin Pharmaceutical Q4 2022 Earnings Preview
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Jan 29 | 63.46 | 62.97 |
64.05
|
62.97
|
938K | 0.33% | |||
| Jan 28 | 63.25 | 62.03 |
63.48
|
61.61
|
1.5M | 2.35% | |||
| Jan 27 | 61.8 | 62.1 |
63.15
|
61.23
|
2.4M | 0.11% | |||
| Jan 24 | 61.73 | 62.51 |
63.06
|
61.36
|
2.7M | -0.74% | |||
| Jan 23 | 62.19 | 61.85 |
62.59
|
61.17
|
2.5M | 0.27% | |||
| Jan 22 | 62.02 | 62.69 |
62.72
|
61.59
|
1.6M | -0.82% | |||
| Jan 21 | 62.53 | 61.7 |
63.03
|
61.56
|
2.3M | 1.63% | |||
| Jan 17 | 61.53 | 61.67 |
62.37
|
61.37
|
2.6M | 0.46% | |||
| Jan 16 | 61.25 | 61.85 |
61.85
|
60.63
|
2.9M | -0.54% | |||
| Jan 15 | 61.58 | 64.04 |
64.72
|
61.38
|
3.1M | -3.49% | |||
| Jan 14 | 63.81 | 67.35 |
67.38
|
63.58
|
1.8M | -4.75% | |||
| Jan 13 | 66.99 | 67.58 |
67.58
|
65.95
|
1.2M | -0.58% | |||
| Jan 10 | 67.38 | 67.26 |
67.94
|
66.01
|
1.2M | -1.46% | |||
| Jan 8 | 68.38 | 67.9 |
69.7
|
67.43
|
1.5M | 0.71% | |||
| Jan 7 | 67.9 | 67.07 |
68.85
|
66.91
|
1.3M | 1.24% | |||
| Jan 6 | 67.07 | 66.93 |
67.75
|
66.7
|
1.0M | 0.36% | |||
| Jan 3 | 66.83 | 66.56 |
67.5
|
66.44
|
843K | 0.51% | |||
| Jan 2 | 66.49 | 65.97 |
66.74
|
65.86
|
870K | 1.16% | |||
| Dec 31, 2024 | 65.73 | 65.74 |
66.16
|
65.33
|
791K | 0.43% | |||
| Dec 30, 2024 | 65.45 | 66.3 |
66.46
|
65.24
|
1.2M | -2.15% | |||
| Dec 27, 2024 | 66.89 | 66.89 |
67.47
|
66.38
|
774K | -0.19% | |||
| Dec 26, 2024 | 67.02 | 66.3 |
67.1
|
66.21
|
926K | 0.59% | |||
| Dec 24, 2024 | 66.63 | 65.96 |
67.09
|
65.25
|
439K | 0.54% | |||
| Dec 23, 2024 | 66.27 | 65.07 |
66.46
|
64.65
|
1.1M | 0.93% | |||
| Dec 20, 2024 | 65.66 | 64.9 |
66.27
|
64.07
|
4.0M | 1.02% | |||
| Dec 19, 2024 | 65 | 64.63 |
65.62
|
63.93
|
1.5M | 0.48% | |||
| Dec 18, 2024 | 64.69 | 67.19 |
67.58
|
64.6
|
1.2M | -3.72% | |||
| Dec 17, 2024 | 67.19 | 64.89 |
67.85
|
64.8
|
1.7M | 2.52% | |||
| Dec 16, 2024 | 65.54 | 66.5 |
67.17
|
65.42
|
1.5M | -0.71% | |||
| Dec 13, 2024 | 66.01 | 66.08 |
66.27
|
64.89
|
772K | -0.38% | |||
| Dec 12, 2024 | 66.26 | 65.45 |
66.68
|
65.35
|
1.0M | 0.44% | |||
| Dec 11, 2024 | 65.97 | 66.42 |
67.05
|
65.49
|
807K | -0.69% | |||
| Dec 10, 2024 | 66.43 | 67 |
67.07
|
66.13
|
839K | -0.57% | |||
| Dec 9, 2024 | 66.81 | 66.33 |
67.87
|
66.33
|
1.8M | 0.10% | |||
| Dec 6, 2024 | 66.74 | 66.89 |
67.2
|
65.79
|
1.6M | 0.88% | |||
| Dec 5, 2024 | 66.16 | 66.05 |
66.92
|
65.38
|
3.8M | -0.53% | |||
| Dec 4, 2024 | 66.51 | 63.14 |
66.71
|
62.84
|
2.9M | 5.25% | |||
| Dec 3, 2024 | 63.19 | 64.7 |
65.13
|
63.09
|
1.3M | -2.84% | |||
| Dec 2, 2024 | 65.04 | 65.71 |
65.86
|
64.97
|
1.2M | -1.5% | |||
| Nov 29, 2024 | 66.03 | 65.33 |
66.17
|
65.23
|
700K | 0.93% | |||
| Nov 27, 2024 | 65.42 | 65.16 |
65.52
|
64.64
|
951K | 0.83% | |||
| Nov 26, 2024 | 64.88 | 65 |
65.09
|
64.11
|
1,000K | -0.32% | |||
| Nov 25, 2024 | 65.09 | 64.35 |
65.69
|
64.32
|
2.2M | 1.29% | |||
| Nov 22, 2024 | 64.26 | 63.88 |
64.46
|
63.78
|
1.3M | 1.28% | |||
| Nov 21, 2024 | 63.45 | 62.4 |
63.76
|
61.41
|
1.4M | 1.42% | |||
| Nov 20, 2024 | 62.56 | 61.97 |
62.7
|
61.61
|
1.2M | 0.95% | |||
| Nov 19, 2024 | 61.97 | 61.57 |
62.03
|
61.15
|
1.9M | 0.06% | |||
| Nov 18, 2024 | 61.93 | 63.15 |
63.52
|
61.4
|
2.1M | -2.35% | |||
| Nov 15, 2024 | 63.42 | 66.05 |
66.05
|
63.22
|
1.7M | -3.32% | |||
| Nov 14, 2024 | 65.6 | 66.37 |
67
|
65.53
|
1.4M | -1.59% | |||
| Nov 13, 2024 | 66.66 | 66.18 |
67
|
66
|
1.5M | 0.80% | |||
| Nov 12, 2024 | 66.13 | 65.96 |
66.69
|
65.8
|
1.2M | -0.36% | |||
| Nov 11, 2024 | 66.37 | 67.21 |
67.95
|
66.32
|
905K | -1.04% | |||
| Nov 8, 2024 | 67.07 | 66.76 |
67.44
|
66.67
|
1.1M | 0.19% | |||
| Nov 7, 2024 | 66.94 | 66.32 |
67.3
|
65.75
|
1.4M | 1.19% | |||
| Nov 6, 2024 | 66.15 | 67.31 |
67.64
|
65.79
|
2.0M | 0.17% | |||
| Nov 5, 2024 | 66.04 | 66.23 |
66.23
|
65.45
|
1.6M | 0.05% | |||
| Nov 4, 2024 | 66.01 | 66.24 |
66.59
|
65.56
|
2.0M | -0.89% | |||
| Nov 1, 2024 | 66.6 | 65.7 |
66.81
|
65.6
|
1.6M | 1.08% | |||
| Oct 31, 2024 | 65.89 | 66.68 |
66.92
|
65.35
|
1.8M | 0% | |||